These results suggest ABHD11‐AS1 regulates cell proliferation, cycle, apoptosis and invasion in endometrial cancer—at least in part—by targeting cyclin D1 and in turn the expression of CDK1, CDK2, CDK4, Bcl‐xl, VEGFA and p16. Here, CDK2 is linked to endometrial cancer.